Angiodynamics (ANGO) Non-Current Assets (2011 - 2026)

Angiodynamics has reported Non-Current Assets for 16 years, with the latest figure at $105.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 7.08% year-over-year to $105.1 million; the trailing twelve-month figure through Feb 2026 stood at $434.3 million (down 8.53% YoY), and the FY2025 full-year result was $111.8 million, down 10.13% from the prior year.
• Non-Current Assets for Q1 2026 stood at $105.1 million, down from $108.3 million in the prior quarter.
• The five-year high for Non-Current Assets was $415.5 million in Q1 2022, with the low at $105.1 million in Q1 2026.
• Historically, Non-Current Assets has averaged $238.8 million across 5 years, with a median of $127.9 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets decreased 2.65% — and 2024, when it slumped 67.22%.
• Angiodynamics' Non-Current Assets stood at $399.4 million in 2022, then retreated by 21.34% to $314.2 million in 2023, then slumped by 63.02% to $116.2 million in 2024, then slipped by 6.76% to $108.3 million in 2025, then declined by 2.96% to $105.1 million in 2026.
• The last three Non-Current Assets figures came in at $105.1 million (Q1 2026), $108.3 million (Q4 2025), and $109.0 million (Q3 2025), per Business Quant data.